(Q24319867)
Statements
Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) (English)
0 references
September 2011
0 references
12
0 references
853-60
0 references
9
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference